SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-15-009040
Filing Date
2015-11-23
Accepted
2015-11-23 17:22:12
Documents
11
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0915_amarantusbio.htm 10-Q 670030
2 CERTIFICATION f10q0915ex31i_amarantusbio.htm EX-31.1 15866
3 CERTIFICATION f10q0915ex31ii_amarantusbio.htm EX-31.2 15701
4 CERTIFICATION f10q0915ex32i_amarantusbio.htm EX-32.1 4749
5 CERTIFICATION f10q0915ex32ii_amarantusbio.htm EX-32.2 5038
  Complete submission text file 0001213900-15-009040.txt   3977317

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE ambs-20150930.xml EX-101.INS 620719
7 XBRL SCHEMA FILE ambs-20150930.xsd EX-101.SCH 50288
8 XBRL CALCULATION FILE ambs-20150930_cal.xml EX-101.CAL 39528
9 XBRL DEFINITION FILE ambs-20150930_def.xml EX-101.DEF 234587
10 XBRL LABEL FILE ambs-20150930_lab.xml EX-101.LAB 412432
11 XBRL PRESENTATION FILE ambs-20150930_pre.xml EX-101.PRE 296628
Mailing Address 655 MONTGOMERY STREET SUITE 900 SAN FRANCISCO CA 94111
Business Address 655 MONTGOMERY STREET SUITE 900 SAN FRANCISCO CA 94111 (408) 737-2734
Amarantus Bioscience Holdings, Inc. (Filer) CIK: 0001424812 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55016 | Film No.: 151250509
SIC: 2834 Pharmaceutical Preparations